ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: 2588 • 2018 ACR/ARHP Annual Meeting

    Baseline Pain Severity As a Predictor of Pain Improvement Following Treatment with Tofacitinib in Psoriatic Arthritis

    Alexis Ogdie1, Kurt de Vlam2, Andrew G Bushmakin3, Joseph C Cappelleri3, Philip J. Mease4, Roy Fleischmann5, Peter C. Taylor6, Valderilio F Azevedo7, Lara Fallon8, Anna Maniccia9 and John Woolcott10, 1University of Pennsylvania, Philadelphia, PA, 2UZ Leuven, Leuven, Belgium, 3Pfizer Inc, Groton, CT, 4Swedish Medical Center and University of Washington, Seattle, WA, 5University of Texas Southwestern Medical Center, Dallas, TX, 6University of Oxford, Oxford, United Kingdom, 7Universidade Federal do Paraná, Curitiba, Brazil, 8Pfizer Canada, Montreal, QC, Canada, 9Pfizer Inc, New York, NY, 10Pfizer Inc, Collegeville, PA

    Background/Purpose: Pain is a core domain of psoriatic arthritis (PsA), and it is recommended that all randomized controlled trials (RCTs) in patients (pts) with PsA…
  • Abstract Number: 2594 • 2018 ACR/ARHP Annual Meeting

    Median Time to Pain Improvement in Patients with Psoriatic Arthritis Treated with Tofacitinib

    Kurt de Vlam1, Alexis Ogdie2, Andrew G Bushmakin3, Joseph C Cappelleri3, Roy Fleischmann4, Peter C. Taylor5, Valderilio F Azevedo6, Lara Fallon7, Anna Maniccia8, John Woolcott9 and Philip J. Mease10, 1UZ Leuven, Leuven, Belgium, 2University of Pennsylvania, Philadelphia, PA, 3Pfizer Inc, Groton, CT, 4University of Texas Southwestern Medical Center, Dallas, TX, 5University of Oxford, Oxford, United Kingdom, 6Universidade Federal do Paraná, Curitiba, Brazil, 7Pfizer Canada, Montreal, QC, Canada, 8Pfizer Inc, New York, NY, 9Pfizer Inc, Collegeville, PA, 10Swedish Medical Center and University of Washington, Seattle, WA

    Background/Purpose: Pain is a core domain of psoriatic arthritis (PsA).1 Rapid, sustained pain reduction is a priority for patients (pts) and physicians when choosing treatment.…
  • Abstract Number: 2652 • 2018 ACR/ARHP Annual Meeting

    Engaging the Cholinergic Anti-Inflammatory Pathway By Stimulating the Vagus Nerve Reduces Pain and Fatigue in Patients with SLE

    Cynthia Aranow1, Martin Lesser2, Meggan Mackay1, Erik Anderson3, Theodoros P. Zanos2, Timir Datta-Chaudhuri2, Chad Bouton2, Kevin J. Tracey4 and Betty Diamond1, 1The Feinstein Institute for Medical Research, Manhasset, NY, 2Feinstein Institute for Medical Research, Manhasset, NY, 3Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, NY, 4Laboratory of Biomedical Science, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose:   Musculoskeletal (MS) pain is a common symptom of patients with Systemic Lupus Erythematosus (SLE) affecting up to 95% of patients and contributing to…
  • Abstract Number: 2868 • 2018 ACR/ARHP Annual Meeting

    Tender Joint Count May Not Reflect Inflammatory Activity in Established Rheumatoid Arthritis Patients; Results from a Longitudinal Study of Tocilizumab

    Hilde B Hammer1, Inger Marie Jensen Hansen2, Pentti Järvinen3, Marjatta Leirisalo-Repo4, Michael Ziegelasch5, Birte Agular6 and Lene Terslev7, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rheumatology, Svendborg Hospital, Svendborg, Denmark, 3Rheumatology, Kiljava Medical Research, Kiljavan, Finland, 4Rheumatology, University of Helsinki, Helsinki, Finland, 5Rheumatology, University Hospital, Linköping, Linköping, Sweden, 6Roche, Copenhagen, Denmark, 7Rheumatology, Rigshospitalet Glostrup, Copenhagen, Denmark

    Background/Purpose: Tender joints may be caused by non-inflammatory pathologies but are still included in composite scores like CDAI. The present objective was to explore the…
  • Abstract Number: 405 • 2018 ACR/ARHP Annual Meeting

    Feasibility of Enabling Self-Management and Coping with Arthritic Pain Using Exercise (ESCAPE-Pain) Programme for Knee Osteoarthritis in Malaysia

    Muhammad Kamil Che Hasan1,2, Emma Stanmore2 and Chris Todd2, 1Kulliyyah (Faculty) of Nursing, International Islamic University Malaysia (IIUM), Kuantan Pahang, Malaysia, 2Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: In Malaysia around one in ten older people are diagnosed with osteoarthritis (OA), with the knee being one of the most commonly affected areas.…
  • Abstract Number: 447 • 2018 ACR/ARHP Annual Meeting

    Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol

    Manuel Romero1, Stephen Bruehl2, Gustavo A Reyes del Paso3 and Pablo De la Coba3, 1University Hospital of Jaén, Jaén, Spain, 2Department of Anesthesiology, Vanderbilt University, Nashville, TN, 3Department of Psychology, University of Jaén, Jaén, Spain

    Background/Purpose: In a prior study, the response of pain sensitization by fibromyalgia (FM) patients to a protocol of Slowly Repeated Evoked Pain (SREP)* was strongly…
  • Abstract Number: 450 • 2018 ACR/ARHP Annual Meeting

    Injection Site Reaction Associated with Subcutaneous Biologic Agents and Methotrexate. Analysis from the Rhumadata® Clinical Database and Registry

    Denis Choquette1, Louis Bessette2, Jacques Brown2, Boulos Haraoui1, Frédéric Massicotte1, Jean-Pierre Pelletier1, Jean-Pierre Raynauld1, Marie-Anaïs Rémillard1, Diane Sauvageau1, Angèle Turcotte2, Édith Villeneuve1 and Louis Coupal1, 1Rheumatology, Institut de Recherche en Rhumatologie de Montréal (IRRM), Montréal, QC, Canada, 2Rheumatology, Centre de l'Ostéoporose et de Rhumatologie de Québec (CORQ), Québec, QC, Canada

    Background/Purpose: Injection Site Reaction (ISRs) are associated with the subcutaneous (SC) route of administration of all biologic agents, and 3% to 15% of patients reports…
  • Abstract Number: 933 • 2018 ACR/ARHP Annual Meeting

    Inflammation in the Hippocampus Affects Insulin-like Growth Factor-1 Receptor Signaling and Contributes to Neurological Sequelae in Rheumatoid Arthritis

    Karin Andersson1, Caroline Wasén1, Lina Juzokaite1, Malin C Erlandsson1,2, Anna Stokowska3, Lovisa Leifsdottir4, Marcela Pekna3, Milos Pekny3, Kjell Olmarker5, Rolf Heckemann6,7,8, Marie Kalm9 and Maria I Bokarewa2, 1Department of rheumatology and inflammation research, University of Gothenburg, Gothenburg, Sweden, 2Rheumatology Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden, 3Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden, 4Rheumatology Clinics, Sahlgrenska University Hospital, Gothenburg, Sweden, 5Department of Medical Chemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden, 6Med Tech West at Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden, 7Department of Medical Radiation Science, University of Gothenburg, Gothenburg, Sweden, 8Faculty of Medicine, Imperial College London, London, United Kingdom, 9Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: The central nervous system is not the primary target in rheumatoid arthritis (RA). However, neuropsychiatric symptoms including pain, depression and anxiety are common and…
  • Abstract Number: 1159 • 2018 ACR/ARHP Annual Meeting

    Fat Mass Is Associated with Musculoskeletal Pain in Women : A Three-Year Longitudinal Study

    Hyun Ah Kim and Jeong-Im Hong, Hallym University Sacred Heart Hospital, Kyunggi-do, Korea, Republic of (South)

    Background/Purpose: Increase in fat mass is correlated with musculoskeletal pain. The aim of this study was to examine the relationship between fat mass and the…
  • Abstract Number: 614 • 2017 ACR/ARHP Annual Meeting

    Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

    Alexis Ogdie1, Kurt de Vlam2, Iain B. McInnes3, Philip J Mease4, Philip Baer5, Tatjana Lukic6, Kenneth Kwok6, Cunshan Wang7, Ming-Ann Hsu7 and Anna Maniccia6, 1Division of Rheumatology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2UZ Leuven, Leuven, Belgium, 3Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom, 4Swedish Medical Center and University of Washington, Seattle, WA, 5Baer Weinberg MPC, Scarborough, ON, Canada, 6Pfizer Inc, New York, NY, 7Pfizer Inc, Groton, CT

    Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), which has also been evaluated in other inflammatory rheumatic diseases…
  • Abstract Number: 860 • 2017 ACR/ARHP Annual Meeting

    Effective Treatment of Persistent Arthritis Pain Requires Co-Modulation of TNF and Type I Interferon

    Sarah Woller1, Tony Yaksh2 and Maripat Corr3, 1Anesthesiology, UCSD, La Jolla, CA, 2Anesthesiology 0818, UCSD, La Jolla, CA, 3Division of Rheumatology, Allergy, and Immunology, UCSD, La Jolla, CA

    Background/Purpose: Pain persisting beyond the resolution or control of clinical signs of rheumatoid arthritis (RA) decreases quality of life for millions of people. Unfortunately, this…
  • Abstract Number: 1261 • 2017 ACR/ARHP Annual Meeting

    The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Sera Ramadan1, Perry M. Nicassio2, George Karpouzas3 and Sarah Ormseth4, 1Internal Medicine, Dignity Health St. Mary Medical Center, Long Beach, CA, 2Cousins Center for PNI, UCLA, LA, CA, 3Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 4Rheumatology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: This research tested an integrated framework examining patient global assessment of disease activity (PtGA), maladaptive illness beliefs and pain as determinants of mood disturbance…
  • Abstract Number: 1345 • 2017 ACR/ARHP Annual Meeting

    Tender Joints Have Low Associations with Patient’s Evaluation of Joint Pain and Ultrasound Findings Explored at Joint Level in Patients with Rheumatoid Arthritis

    Hilde B Hammer1, Joseph Sexton1, Sella A. Provan2, Brigitte Michelsen3,4 and Tore Kvien5, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Rheumatology, Hospital of Southern Norway trust, Kristiansand, Norway, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: In patients with rheumatoid arthritis (RA) the pain experience in joints with different degrees of joint inflammation is highly individual and dependent upon the…
  • Abstract Number: 1602 • 2017 ACR/ARHP Annual Meeting

    Fatigue in Systemic Lupus: The Role of Disease Activity and Its Mediators

    Desiree R Azizoddin1, Meenakshi Jolly2, Joel A. Block3 and Perry M. Nicassio4, 1Department of Medicine and Behavioral Sciences, Rush University, Chicago, IL, 2Rush, Chicago, IL, 3Division of Rheumatology, Rush University Medical Center, Chicago, IL, 4Cousins Center for PNI, UCLA, LA, CA

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that leads to a variety of negative health outcomes. Though treatment continues to advance, fatigue…
  • Abstract Number: 2210 • 2017 ACR/ARHP Annual Meeting

    Thumb Base Osteoarthritis: Associations between Pain and Synovitis on Ultrasound

    F.P.B. Kroon1, S. Ermurat2, M. Kortekaas1, M. Reijnierse3 and M. Kloppenburg1,4, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Uludag University Medical Faculty, Bursa, Turkey, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Osteoarthritis (OA) in the first carpometacarpal (CMC1) joint in the thumb base is frequent and has a large contribution in hand pain and disability.…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology